hyperaldosteronism
HYPERALDOSTERONISM
Hyperaldosteronism is a group of disorders in which aldosterone production is inappropriately high, relatively autonomous & non-suppressible by sodium loading.
Signs & symptoms are nonspecific.
Symptoms are caused by hypertension (eg headache), hypokalemia (eg polyuria, nocturia, muscle cramps & weakness, tetany, paralysis, etc) & metabolic alkalosis.

Diagnosis

  • Correct hypokalemia before performing diagnostic studies

Laboratory Tests

Plasma Aldosterone Concentration/Plasma Renin Activity (PAC/PRA) or Aldosterone:Renin Ratio (ARR)

  • Reliable means of identifying patients with primary hyperaldosteronism and patients whose hypertension may be treatable with Spironolactone
  • Controversy over whether antihypertensives should be stopped prior to Aldosterone:Renin ratio tests
  • An ARR ≥25 when plasma aldosterone level is ≥15 ng/dL suggests hyperaldosteronism

Definitive Test

Definitive Biochemical Diagnosis

  • Stop antihypertensives or agents for ≥4 weeks prior to diagnostic tests (eg Spironolactone, Eplerenone, Amiloride, Triamterene, potassium-wasting diuretics, products derived from licorice root)
    • Medications that are less likely to affect renin and aldosterone measurements (eg Verapamil slow-release, Hydralazine, Doxazosin, Terazosin, Guanethidine or Prazosin) may be used in patients who are not on antihypertensive medication
  • Controversy whether definitive biochemical diagnosis is necessary

Diagnostic Tests

  • High rate of urinary aldosterone excretion with diet high in sodium chloride (NaCl) [eg 12.8 g NaCl or 5000 mg of sodium (Na) x 3 days]
    • Urinary aldosterone excretion rate <10 mcg/24 hours after Na load rules out primary aldosteronism (except glucocorticoid-remediable type); essential hypertension is likely

      Or

  • High plasma aldosterone level after intravenous (IV) infusion of NS [eg 2 L of 0.9% NaCl continuous IV given over 4 hours (from 8 am - 12 noon)]
    • Postinfusion plasma aldosterone levels of <5 ng/dL make primary aldosteronism unlikely, while levels >10 ng/dL are a very probable sign of primary aldosteronism

Followed By:

  • Low plasma renin activity with low Na consumption (<40 mg/day) or use of diuretic [eg Furosemide 120 mg per orem (PO) in divided doses] suggests diagnosis of primary aldosteronism

Evaluation

  • Patients with the following should receive evaluation for hyperaldosteronism:
    • Sustained hypertension (≥150 mmHg systolic or ≥100 mmHg diastolic)
    • Hypertensive patient with spontaneous or profound diuretic-induced hypokalemia
    • Untreated hypertension with low serum K+ levels (~3.5 mmol/L)
    • Refractory hypertension or patients receiving ≥3 antihypertensives
    • High risk for aldosteronism (resistant hypertension or incidental imaging of abnormal adrenal gland)
    • Family history of early-onset hypertension or cerebrovascular accident (CVA) at a young age (<40 years old)
    • Hypertensive 1st-degree relatives of patients w/ primary aldosteronism

Imaging

Magnetic Resonance Imaging/Computed Tomography (MRI/CT) scan

  • MRI or CT of adrenal glands to diagnose adrenal adenomata
    • MRI is not more sensitive than CT

Adrenal Venous Sampling

  • Adrenal vein catheterization should only be performed by an experienced radiologist
  • Aids imaging studies in determining whether any adrenal masses or nodules represent adenoma or hyperplasia
  • Samples of adrenal venous blood are taken for the measurement of aldosterone and cortisol from the adrenal venous effluent & from the inferior vena cava
  • Distinguishes between unilateral and bilateral adrenal disease when surgery can be done and is desired by patient
    • Unilateral adrenal hyperplasia can be determined by unilateral excess of aldosterone secretion which usually indicates presence of aldosteronoma
    • In patients with bilateral adrenal disease, consider genetic testing for glucocorticoid-remediable aldosteronism if they have confirmed primary aldosteronism with family history of aldosteronism or of strokes at <40 years of age, or with hypertension starting at <20 years of age
  • Adrenal venous sampling may not be needed in patients age <35 years with spontaneous hypokalemia, marked excess aldosterone, and unilateral adrenal lesions with features found in radiography consistent with a cortical adenoma on adrenal CT scan
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Jun 2015
Long-term oral testosterone undecanoate significantly improved IPSS quality of life scores in a 1-year, randomised, multicentre, double-blind trial among aging hypogonadal men.
Rachel Soon, 01 Jun 2016

The inclusion of statins in managing chronic kidney disease (CKD) may help reduce patient mortality from stroke and possibly other cardiovascular events, according to an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Rachel Soon, 01 Jun 2016

Patients with hypercholesterolaemia with unchanging LDL-cholesterol levels after 6 weeks of statin treatment should be actively assessed for either statin intolerance or resistance, says an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Prof. Cyrus Rustam Kumana, 07 Jul 2016

This case scenario was presented at a grand round in the Department of Medicine, The University of Hong Kong. Unlike traditional grand rounds that directly or indirectly deal with clinical challenges posed by patients, this one was equally about doctors and how they care for their charges. All doctors who tend patients dread being implicated on the receiving end of medico-legal proceedings. This topic is therefore intimately linked to the professionalism of doctors, their standing in the community, and the ethical aspects of how they interact with patients and relatives.